- Home
- LUNG vs FCT Comparison
LUNG vs FCT Comparison
Compare LUNG & FCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LUNG
- FCT
- Stock Information
- Founded
- LUNG 1995
- FCT 2004
- Country
- LUNG United States
- FCT United States
- Employees
- LUNG N/A
- FCT N/A
- Industry
- LUNG Industrial Specialties
- FCT Finance Companies
- Sector
- LUNG Health Care
- FCT Finance
- Exchange
- LUNG Nasdaq
- FCT Nasdaq
- Market Cap
- LUNG 248.0M
- FCT 268.9M
- IPO Year
- LUNG 2020
- FCT N/A
- Fundamental
- Price
- LUNG $7.30
- FCT $10.29
- Analyst Decision
- LUNG Strong Buy
- FCT
- Analyst Count
- LUNG 7
- FCT 0
- Target Price
- LUNG $13.71
- FCT N/A
- AVG Volume (30 Days)
- LUNG 237.6K
- FCT 106.8K
- Earning Date
- LUNG 10-28-2024
- FCT 01-01-0001
- Dividend Yield
- LUNG N/A
- FCT 11.29%
- EPS Growth
- LUNG N/A
- FCT N/A
- EPS
- LUNG N/A
- FCT N/A
- Revenue
- LUNG $76,583,000.00
- FCT N/A
- Revenue This Year
- LUNG $22.73
- FCT N/A
- Revenue Next Year
- LUNG $19.02
- FCT N/A
- P/E Ratio
- LUNG N/A
- FCT N/A
- Revenue Growth
- LUNG 26.26
- FCT N/A
- 52 Week Low
- LUNG $5.46
- FCT $9.45
- 52 Week High
- LUNG $14.84
- FCT $10.42
- Technical
- Relative Strength Index (RSI)
- LUNG 41.60
- FCT 48.61
- Support Level
- LUNG $7.18
- FCT $10.18
- Resistance Level
- LUNG $8.59
- FCT $10.36
- Average True Range (ATR)
- LUNG 0.40
- FCT 0.09
- MACD
- LUNG -0.16
- FCT -0.00
- Stochastic Oscillator
- LUNG 7.74
- FCT 37.93
About LUNG Pulmonx Corporation
Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.
About FCT First Trust Senior Floating Rate Income Fund II of Beneficial Interest
First Trust Senior Floating Rate Income Fund II is the United States based diversified, closed-end management investment company. Its investment objective is to seek a high level of current income. As a secondary objective, the fund attempts to preserve capital. The fund seeks to achieve the objectives by investing in a portfolio of senior floating-rate loan interests. Its portfolio of investments consists of aerospace and defense, agricultural products, broadcasting, cable and satellite, electric utilities and other sectors.